Forced degradation studies on axitinib and characterization of its degradation products by liquid chromatography‐high resolution mass spectrometry and nuclear magnetic resonance spectroscopy along with its <i>in</i> <i>silico</i> toxicity assessment-Reference-Cited by-同舟云学术

Forced degradation studies on axitinib and characterization of its degradation products by liquid chromatography‐high resolution mass spectrometry and nuclear magnetic resonance spectroscopy along with its in silico toxicity assessment

Published:2022-06-02 Issue:8 Volume:5 Page:431-441
ISSN:2573-1815
Container-title:SEPARATION SCIENCE PLUS
language:en
Short-container-title:Separation Science Plus

Author:

Kushwah Bhoopendra Singh¹,Golla Vijaya Madhyanapu¹,Dhiman Vivek¹,Samanthula Gananadhamu¹^ORCID

Affiliation:

1. Department of Pharmaceutical Analysis National Institute of Pharmaceutical Education and Research Hyderabad India

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sscp.202200043

Reference28 articles.

1. Clinical Pharmacology of Axitinib

2. Axitinib: A Review of its Safety and Efficacy in the Treatment of Adults with Advanced Renal Cell Carcinoma

3. ICH Q1A (R2).Stability testing of new drug substances and products.2003.

4. ICH Q1B.Stability testing: photostability testing of new drug substances and products.1996.

5. A liquid chromatography‐tandem mass spectrometric method for the determination of axitinib in nude mouse plasma: development, validation and application to a pharmacokinetic study;Ma Y;J Chin Pharm Sci.,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemometrics‐Empowered Optimization of a Reliable Reversed Phase–High Performance Liquid Chromatography Method for the Simultaneous Estimation of Erythromycin and Adapalene in Pharmaceutical Nanoformulation;SEPARATION SCIENCE PLUS;2024-08-06

2. Encequidar Mesylate Novel Degradation Products: Isolation, Characterization, and Structural Evaluation Using Mass‐Triggered Preparative HPLC, HRMS, and NMR Techniques;SEPARATION SCIENCE PLUS;2024-08-02

3. Novel Stability–Indicating Reverse‐Phase High‐Performance Liquid Chromatography Technique for Apremilast Quantification in Pharmaceuticals and Nanovesicular Systems: A Design of Experiment Approach;SEPARATION SCIENCE PLUS;2024-06-16

4. LC-HRMS and NMR studies for the characterization of degradation impurities of ubrogepant along with the in silico approaches for the prediction of degradation and toxicity;Journal of Pharmaceutical and Biomedical Analysis;2024-06

5. Identification, characterisation and in silico ADMET prediction of ozenoxacin and its degradation products using high‐performance liquid chromatography‐photodiode array and liquid chromatography‐quadrupole time‐of‐flight‐tandem mass spectrometry;Rapid Communications in Mass Spectrometry;2023-12-07